NEW YORK, Dec. 30 (GenomeWeb News) - Hycor Biomedical yesterday said it had signed an agreement with privately held Stratagene to extend the deadline for closing its proposed merger with the company until Feb. 27, 2004.

All other terms of the merger agreement, announced in July and originally expected to close in the fourth quarter of 2003, remain the same, according to Hycor.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.